Viromed Medical AG: Successful Completion of Capital Increase

What happened

Viromed Medical AG said it completed a capital increase announced the same day, placing 450,000 new shares at EUR 4.50 each for gross proceeds of about EUR 2 million, to be used to finance working capital.

Confirmed

Global impact / market context

New shares raise cash the company says it needs to run day-to-day operations, which is working capital, but issuing shares without offering them first to existing holders dilutes those holders, meaning their ownership stake shrinks.

Confirmed

The placement adds 450,000 shares to the total, lifting share capital to EUR 21,700,000 once registered, so investors will weigh the extra cash against a smaller share of future profits per share.

Analyst inference

What to watch

1. Watch whether the capital increase is entered in the commercial register, since the share capital rise from EUR 21,250,000 to EUR 21,700,000 depends on that registration. Confirmed
2. Track how quickly the roughly EUR 2 million is spent on working capital and whether the company reports improved cash available or needs more funding later. Analyst inference
3. Note that the shares were placed without subscription rights, so existing holders could not buy first; watch whether this affects investor positioning in the stock. Analyst inference

Evidence

• eqs-news.com